LOADING
Comparing Salesforce Inc (CRM) and Thermo Fisher Scientific (TMO) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | CRM | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $142.2B | $212.7B |
| P/E Ratio | 20.1 | 31.1 |
| Forward P/E | 12.8 | 23.0 |
| PEG Ratio | 0.72 | 1.88 |
| EPS | $9.02 | $18.56 |
| Revenue Growth (YoY) | 13.3% | 10.5% |
| Profit Margin | 18.7% | 15.0% |
| Return on Equity | 16.9% | 13.5% |
| Dividend Yield | 0.97% | 0.15% |
| Beta | 1.18 | 0.87 |
| 52-Week High | $267.75 | $642.71 |
| 52-Week Low | $146.32 | $434.83 |
| Volume | -- | -- |
Thermo Fisher Scientific is the larger company by market capitalization. Salesforce Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Salesforce Inc offers a higher dividend yield for income investors. Salesforce Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.